NBTI Leadership

The Northwestern Brain Tumor Institute is dedicated to providing state-of-the-art clinical care, along with the resources and support that patients and families need. This requires the services of a multidisciplinary team of experts in brain and spinal disease.

Leading this world-class team are the co-directors of the Northwestern Brain Tumor Institute, James Chandler, MD and Jeffrey Raizer, MD.


James Chandler, MD - Co-Director

James Chandler, MD

James Chandler, MD, is the Surgical Director of Neuro-Oncology at Northwestern Memorial Hospital and a Professor of Neurological Surgery and Otolaryngology — Head and Neck Surgery at Northwestern University Feinberg School of Medicine. Dr. Chandler received his undergraduate degree in neurobiology at the University of California at Berkeley and his medical degree from the University of Maryland Medical School in Baltimore. He completed his residency in neurological surgery at Northwestern's Feinberg School of Medicine and completed fellowships in cranial base and micro vascular surgery at the George Washington Neurological Institute in Washington, D.C., and at the Institute Neurosurgery Sao Paulo (Brazil). Dr. Chandler has performed over 3500 successful brain tumor operations and has authored numerous publications on the topic. He enjoys an international reputation for his pioneering work in the areas of endoscopic skull base surgery, awake craniotomy and outpatient brain surgery.

"Creation of the Brain Tumor Institute firmly establishes Northwestern as a preeminent resource in efforts to help us improve care for patients now and in the future," says Dr. Chandler. "Northwestern boasts an incredible team of experts in the fields of neurology, neurosurgery, neuro-oncology, and radiation, along with a team of internationally-renowned research scientists. The NBTI unites these minds in pursuit of our efforts to offer patients hope for a healthier future."

View Publication and Abstract Listings


Roger Stupp, MD - Co-Director

Roger Stupp, MD – Co-Director

Roger Stupp, MD, is Chief of Neuro-Oncology at Northwestern Memorial Hospital and Associate Director for Strategic Initiatives at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. A leading authority on the treatment of primary and metastatic brain cancer, Dr. Stupp is also Professor of Neurological Surgery, Medicine (Hematology and Oncology) and Neurology (Neuro-oncology) at Northwestern University Feinberg School of Medicine.

Prior to joining Northwestern in 2017, Dr. Stupp was director of the Department of Oncology at the University of Zurich Hospital in Switzerland and of the Zurich Cancer Center. He earned his medical degree from the University of Zurich and completed an internship and residency in internal medicine at the Langenthal/Bern County Hospital and University Hospital Zurich. Dr. Stupp then moved to the United States for a three-year fellowship in hematology/oncology at the University of Chicago before joining Switzerland's Lausanne University Hospital and the University of Lausanne where he became director of oncology clinical research and head of neuro-oncology in the Department of Neurosurgery.

In 2005, Stupp led clinical research demonstrating that chemotherapy with the drug temozolomide in conjunction with radiotherapy increases survival for patients with glioblastoma. This treatment, known as the Stupp Protocol, has become the standard of care for patients with GBM. Recently, Dr Stupp and colleagues showed that electromagnetic waves called tumor treating fields can substantially improve outcomes for patients suffering from glioblastoma. These breakthrough discoveries led to the last two FDA-approved treatments for the disease.

View Publication and Abstract Listings


 

Facebook Facebook You Tube